TEVA logo

TEVA EBIT

Annual EBIT:

-$369.00M-$774.00M(-191.11%)
December 31, 2024

Summary

  • As of today, TEVA annual earnings before interest & taxes is -$369.00 million, with the most recent change of -$774.00 million (-191.11%) on December 31, 2024.
  • During the last 3 years, TEVA annual EBIT has fallen by -$1.92 billion (-123.82%).
  • TEVA annual EBIT is now -109.37% below its all-time high of $3.94 billion, reached on December 31, 2014.

Performance

TEVA EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

Quarterly EBIT:

$1.08B+$129.63M(+13.64%)
September 30, 2025

Summary

  • As of today, TEVA quarterly earnings before interest & taxes is $1.08 billion, with the most recent change of +$129.63 million (+13.64%) on September 30, 2025.
  • Over the past year, TEVA quarterly EBIT has increased by +$86.03 million (+8.65%).
  • TEVA quarterly EBIT is now -17.93% below its all-time high of $1.32 billion, reached on June 30, 2015.

Performance

TEVA Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

TTM EBIT:

$3.60B+$86.03M(+2.45%)
September 30, 2025

Summary

  • As of today, TEVA TTM earnings before interest & taxes is $3.60 billion, with the most recent change of +$86.03 million (+2.45%) on September 30, 2025.
  • Over the past year, TEVA TTM EBIT has dropped by -$172.58 million (-4.57%).
  • TEVA TTM EBIT is now -29.19% below its all-time high of $5.09 billion, reached on December 31, 2015.

Performance

TEVA TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

TEVA EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-191.1%+8.7%-4.6%
3Y3 Years-123.8%+69.3%+28.2%
5Y5 Years+16.7%+51.7%+23.0%

TEVA EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-123.8%+83.5%-17.6%+116.0%-4.6%+40.2%
5Y5-Year-123.8%+89.5%-17.6%+116.0%-4.6%+40.2%
All-TimeAll-Time-109.4%+97.9%-17.9%+265.9%-29.2%+749.6%

TEVA EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
$1.08B(+13.6%)
$3.60B(+2.4%)
Jun 2025
-
$950.39M(+38.9%)
$3.52B(+4.0%)
Mar 2025
-
$684.00M(-22.9%)
$3.38B(+0.8%)
Dec 2024
-$369.00M(-191.1%)
$887.00M(-10.8%)
$3.35B(-11.2%)
Sep 2024
-
$994.00M(+22.1%)
$3.77B(+7.5%)
Jun 2024
-
$814.00M(+24.1%)
$3.51B(+4.9%)
Mar 2024
-
$656.00M(-49.9%)
$3.35B(+4.9%)
Dec 2023
$405.00M(+118.1%)
$1.31B(+79.0%)
$3.19B(+19.9%)
Sep 2023
-
$732.00M(+12.6%)
$2.66B(+3.7%)
Jun 2023
-
$650.00M(+30.0%)
$2.57B(-0.3%)
Mar 2023
-
$500.00M(-36.0%)
$2.58B(-4.3%)
Dec 2022
-$2.23B(-244.2%)
$781.00M(+22.4%)
$2.69B(-4.1%)
Sep 2022
-
$638.00M(-3.2%)
$2.81B(-1.1%)
Jun 2022
-
$659.00M(+7.0%)
$2.84B(-4.2%)
Mar 2022
-
$616.00M(-31.3%)
$2.96B(-3.4%)
Dec 2021
$1.55B(+144.2%)
$896.00M(+34.1%)
$3.07B(+5.1%)
Sep 2021
-
$668.00M(-14.7%)
$2.92B(-1.5%)
Jun 2021
-
$783.00M(+8.6%)
$2.96B(+4.4%)
Mar 2021
-
$721.00M(-3.4%)
$2.84B(-5.0%)
Dec 2020
-$3.50B(-691.2%)
$746.00M(+4.8%)
$2.98B(+2.0%)
Sep 2020
-
$712.00M(+8.4%)
$2.93B(+0.2%)
Jun 2020
-
$657.00M(-24.5%)
$2.92B(+0.1%)
Mar 2020
-
$870.00M(+26.5%)
$2.92B(+8.0%)
Dec 2019
-$443.00M(+73.6%)
$688.00M(-2.4%)
$2.70B(+6.0%)
Sep 2019
-
$705.00M(+7.6%)
$2.55B(+1.9%)
Jun 2019
-
$655.00M(0.0%)
$2.50B(-3.5%)
Mar 2019
-
$655.00M(+22.4%)
$2.59B(-9.6%)
Dec 2018
-$1.68B(+90.4%)
$535.00M(-18.7%)
$2.87B(-12.0%)
Sep 2018
-
$658.00M(-11.7%)
$3.26B(-7.0%)
Jun 2018
-
$745.00M(-20.0%)
$3.50B(-8.7%)
Mar 2018
-
$931.00M(+0.6%)
$3.84B(-3.8%)
Dec 2017
-$17.50B(-1377.7%)
$925.00M(+2.3%)
$3.99B(-7.9%)
Sep 2017
-
$904.00M(-16.2%)
$4.33B(+0.4%)
Jun 2017
-
$1.08B(-0.4%)
$4.32B(-3.6%)
Mar 2017
-
$1.08B(-14.5%)
$4.48B(-3.8%)
Dec 2016
$1.37B(-47.7%)
$1.27B(+42.6%)
$4.65B(+1.6%)
Sep 2016
-
$888.00M(-28.3%)
$4.58B(-8.5%)
Jun 2016
-
$1.24B(-1.6%)
$5.00B(-1.5%)
Mar 2016
-
$1.26B(+5.4%)
$5.08B(-0.1%)
Dec 2015
$2.62B(-33.4%)
$1.19B(-8.9%)
$5.09B(+0.3%)
Sep 2015
-
$1.31B(-0.4%)
$5.07B(+3.2%)
Jun 2015
-
$1.32B(+4.0%)
$4.91B(+4.8%)
Mar 2015
-
$1.26B(+7.4%)
$4.69B(+4.6%)
Dec 2014
$3.94B(+151.8%)
$1.18B(+2.0%)
$4.48B(+15.6%)
Sep 2014
-
$1.16B(+6.1%)
$3.88B(+3.0%)
Jun 2014
-
$1.09B(+2.7%)
$3.76B(+3.5%)
Mar 2014
-
$1.06B(+84.9%)
$3.64B(+2.1%)
Dec 2013
$1.56B(-28.1%)
$573.31M(-45.0%)
$3.56B(-10.0%)
Sep 2013
-
$1.04B(+8.6%)
$3.96B(+0.4%)
Jun 2013
-
$960.02M(-2.7%)
$3.94B(-1.8%)
Mar 2013
-
$986.45M(+1.9%)
$4.02B(-1.1%)
Dec 2012
$2.17B(-31.8%)
$968.33M(-5.8%)
$4.06B(+10.5%)
Sep 2012
-
$1.03B(-0.5%)
$3.67B(-1.8%)
Jun 2012
-
$1.03B(+0.4%)
$3.74B(+3.6%)
Mar 2012
-
$1.03B(+76.7%)
$3.61B(+3.3%)
Dec 2011
$3.19B(-17.1%)
$582.92M(-46.7%)
$3.50B(-13.2%)
Sep 2011
-
$1.09B(+21.1%)
$4.03B(-3.1%)
Jun 2011
-
$902.78M(-1.4%)
$4.16B(-4.1%)
Mar 2011
-
$915.82M(-17.8%)
$4.34B(+1.0%)
Dec 2010
$3.85B(+60.0%)
$1.11B(-8.9%)
$4.29B(+4.5%)
Sep 2010
-
$1.22B(+13.2%)
$4.11B(+10.3%)
Jun 2010
-
$1.08B(+24.1%)
$3.72B(+10.0%)
Mar 2010
-
$871.30M(-6.4%)
$3.39B(+10.0%)
Dec 2009
$2.40B(+110.0%)
$931.22M(+10.7%)
$3.08B(+7.7%)
Sep 2009
-
$840.91M(+13.4%)
$2.86B(+7.0%)
Jun 2009
-
$741.73M(+31.9%)
$2.67B(+4.7%)
Mar 2009
-
$562.42M(-20.8%)
$2.55B(-4.2%)
Dec 2008
$1.15B(-52.2%)
$710.03M(+8.4%)
$2.66B(+1.0%)
Sep 2008
-
$655.11M(+5.1%)
$2.64B(+0.2%)
Jun 2008
-
$623.08M(-7.6%)
$2.63B(-1.3%)
Mar 2008
-
$674.67M(-1.4%)
$2.67B(+9.4%)
Dec 2007
$2.40B(+14.3%)
$684.43M(+5.4%)
$2.44B(+8.8%)
Sep 2007
-
$649.63M(-1.4%)
$2.24B(-3.0%)
Jun 2007
-
$658.93M(+48.0%)
$2.31B(-0.5%)
Mar 2007
-
$445.29M(-8.4%)
$2.32B(+6.4%)
Dec 2006
$2.10B(+59.8%)
$486.37M(-32.3%)
$2.18B(+6.7%)
Sep 2006
-
$718.17M(+7.0%)
$2.04B(+25.3%)
Jun 2006
-
$671.35M(+119.7%)
$1.63B(+28.5%)
Mar 2006
-
$305.51M(-12.6%)
$1.27B(-2.5%)
DateAnnualQuarterlyTTM
Dec 2005
$1.31B(+11.7%)
$349.71M(+14.6%)
$1.30B(+0.6%)
Sep 2005
-
$305.24M(-1.4%)
$1.29B(-0.9%)
Jun 2005
-
$309.61M(-8.3%)
$1.31B(+1.3%)
Mar 2005
-
$337.70M(-1.2%)
$1.29B(+8.1%)
Dec 2004
$1.18B(+32.8%)
$341.65M(+7.7%)
$1.19B(+10.3%)
Sep 2004
-
$317.16M(+8.4%)
$1.08B(+11.7%)
Jun 2004
-
$292.64M(+21.6%)
$967.92M(+12.0%)
Mar 2004
-
$240.66M(+4.5%)
$864.18M(+7.9%)
Dec 2003
$884.80M(+68.9%)
$230.36M(+12.8%)
$800.86M(+7.0%)
Sep 2003
-
$204.26M(+8.1%)
$748.73M(+12.8%)
Jun 2003
-
$188.90M(+6.5%)
$663.83M(+14.8%)
Mar 2003
-
$177.33M(-0.5%)
$578.27M(+13.6%)
Dec 2002
$524.00M(+39.2%)
$178.23M(+49.3%)
$509.14M(+20.7%)
Sep 2002
-
$119.37M(+15.5%)
$421.72M(+5.6%)
Jun 2002
-
$103.33M(-4.5%)
$399.35M(+4.6%)
Mar 2002
-
$108.20M(+19.1%)
$381.84M(+8.5%)
Dec 2001
$376.46M(+0.3%)
$90.82M(-6.4%)
$351.78M(+34.8%)
Sep 2001
-
$96.99M(+13.0%)
$260.96M(+59.2%)
Jun 2001
-
$85.82M(+9.8%)
$163.96M(+109.8%)
Mar 2001
-
$78.14M(>+9900.0%)
$78.14M(>+9900.0%)
Dec 2000
$375.21M(+40.3%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2000
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2000
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2000
-
$0.00(-100.0%)
$0.00(+100.0%)
Dec 1999
$267.47M(+31.3%)
-
-
Dec 1998
$203.73M(+17.2%)
-
-
Sep 1998
-
$38.70M(+67.9%)
-$554.39M(-80.9%)
Jun 1998
-
$23.05M(-34.2%)
-$306.39M(-421.6%)
Mar 1998
-
$35.06M(+105.4%)
-$58.74M(-133.8%)
Dec 1997
$173.80M(+34.4%)
-$651.20M(-327.1%)
$173.80M(-37.5%)
Sep 1997
-
$286.70M(+5.9%)
$278.20M(+22.0%)
Jun 1997
-
$270.70M(+1.2%)
$228.10M(+9.9%)
Mar 1997
-
$267.60M(+148.9%)
$207.60M(+60.6%)
Dec 1996
$129.30M(+24.1%)
-$546.80M(-331.1%)
$129.30M(-57.7%)
Sep 1996
-
$236.60M(-5.4%)
$305.50M(+30.4%)
Jun 1996
-
$250.20M(+32.2%)
$234.20M(+66.3%)
Mar 1996
-
$189.30M(+151.1%)
$140.80M(+35.1%)
Dec 1995
$104.20M(+0.7%)
-$370.60M(-324.2%)
$104.20M(-31.1%)
Sep 1995
-
$165.30M(+5.4%)
$151.20M(+16.8%)
Jun 1995
-
$156.80M(+2.7%)
$129.40M(+8.3%)
Mar 1995
-
$152.70M(+147.2%)
$119.50M(+15.5%)
Dec 1994
$103.50M(+17.6%)
-$323.60M(-325.5%)
$103.50M(-28.3%)
Sep 1994
-
$143.50M(-2.3%)
$144.40M(+12.7%)
Jun 1994
-
$146.90M(+7.5%)
$128.10M(+20.6%)
Mar 1994
-
$136.70M(+148.4%)
$106.20M(+20.8%)
Dec 1993
$88.00M(+60.9%)
-$282.70M(-322.2%)
$87.90M(-41.6%)
Sep 1993
-
$127.20M(+1.8%)
$150.50M(+29.4%)
Jun 1993
-
$125.00M(+5.6%)
$116.30M(+38.0%)
Mar 1993
-
$118.40M(+153.8%)
$84.30M(+43.4%)
Dec 1992
$54.70M(+5.0%)
-$220.10M(-336.7%)
$58.80M(-32.1%)
Sep 1992
-
$93.00M(0.0%)
$86.60M(+19.8%)
Jun 1992
-
$93.00M(+0.1%)
$72.30M(+26.6%)
Mar 1992
-
$92.90M(+148.3%)
$57.10M(+10.9%)
Dec 1991
$52.10M(+29.3%)
-$192.30M(-344.3%)
$51.50M(-45.8%)
Sep 1991
-
$78.70M(+1.2%)
$95.00M(+20.4%)
Jun 1991
-
$77.80M(-10.9%)
$78.90M(+11.6%)
Mar 1991
-
$87.30M(+158.7%)
$70.70M(+44.0%)
Dec 1990
$40.30M(-8.8%)
-$148.80M(-337.7%)
$49.10M(+6.0%)
Sep 1990
-
$62.60M(-10.1%)
$46.30M(-2.5%)
Jun 1990
-
$69.60M(+5.9%)
$47.50M(+1.7%)
Mar 1990
-
$65.70M(+143.3%)
$46.70M(-5.1%)
Dec 1989
$44.20M(+96.4%)
-$151.60M(-337.6%)
$49.20M(-37.4%)
Sep 1989
-
$63.80M(-7.3%)
$78.60M(+28.0%)
Jun 1989
-
$68.80M(+0.9%)
$61.40M(+43.8%)
Mar 1989
-
$68.20M(+155.8%)
$42.70M(+74.3%)
Dec 1988
$22.50M(+16.6%)
-$122.20M(-362.2%)
$24.50M(-83.3%)
Sep 1988
-
$46.60M(-7.0%)
$146.70M(+14.1%)
Jun 1988
-
$50.10M(+0.2%)
$128.60M(+22.6%)
Mar 1988
-
$50.00M(+75.4%)
$104.90M(+2284.1%)
Sep 1987
-
$28.50M(+8.0%)
$4.40M(-59.3%)
Jun 1987
-
$26.40M(+130.9%)
$10.80M(-44.0%)
Mar 1987
$19.30M(+62.2%)
-$85.40M(-344.7%)
$19.30M(-60.0%)
Dec 1986
-
$34.90M(0.0%)
$48.20M(+33.5%)
Sep 1986
-
$34.90M(0.0%)
$36.10M(+50.4%)
Jun 1986
-
$34.90M(+161.8%)
$24.00M(+101.7%)
Mar 1986
$11.90M
-$56.50M(-347.8%)
$11.90M(-82.6%)
Dec 1985
-
$22.80M(0.0%)
$68.40M(+50.0%)
Sep 1985
-
$22.80M(0.0%)
$45.60M(+100.0%)
Jun 1985
-
$22.80M
$22.80M

FAQ

  • What is Teva Pharmaceutical Industries Limited annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual EBIT year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly EBIT year-on-year change?
  • What is Teva Pharmaceutical Industries Limited TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited TTM EBIT year-on-year change?

What is Teva Pharmaceutical Industries Limited annual earnings before interest & taxes?

The current annual EBIT of TEVA is -$369.00M

What is the all-time high annual EBIT for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual earnings before interest & taxes is $3.94B

What is Teva Pharmaceutical Industries Limited annual EBIT year-on-year change?

Over the past year, TEVA annual earnings before interest & taxes has changed by -$774.00M (-191.11%)

What is Teva Pharmaceutical Industries Limited quarterly earnings before interest & taxes?

The current quarterly EBIT of TEVA is $1.08B

What is the all-time high quarterly EBIT for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly earnings before interest & taxes is $1.32B

What is Teva Pharmaceutical Industries Limited quarterly EBIT year-on-year change?

Over the past year, TEVA quarterly earnings before interest & taxes has changed by +$86.03M (+8.65%)

What is Teva Pharmaceutical Industries Limited TTM earnings before interest & taxes?

The current TTM EBIT of TEVA is $3.60B

What is the all-time high TTM EBIT for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM earnings before interest & taxes is $5.09B

What is Teva Pharmaceutical Industries Limited TTM EBIT year-on-year change?

Over the past year, TEVA TTM earnings before interest & taxes has changed by -$172.58M (-4.57%)
On this page